Europe Archives - Page 69 of 93 - Journal for Clinical Studies

Current Edition

Europe

NHS England moves to fast-track clinical trials

NHS England has unveiled new processes designed to fast track clinical trials undertaken across the NHS, and boost access for patients. Working alongside the National...

9 May 2018 Europe clinical | England

Continue Reading →

Europe

Orchard Therapeutics’ OTL-200 Receives Rare Pediatric Disease Designation from FDA for Treatment of Metachromatic Leukodystrophy Orchard’s fourth Rare Pediatric Disease Designation for autologous ex vivo gene therapy.

Orchard Therapeutics, a leading commercial stage company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies, today a...

9 May 2018 Europe designation | FDA

Continue Reading →

Europe

Nanobiotix partners with Weill Cornell Medicine on pre-clinical studies to evaluate the impact of NBTXR3 on cGAS-STING pathway in mammary cancers

NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, announced today th...

9 May 2018 Europe Cornell | medicine

Continue Reading →

Europe

Research team uncovers mechanism of action for a class of pore-forming bacterial toxins

Pore-forming toxins are common bacterial poisons. They attack organisms by introducing holes in cell membranes. A team of scientists at the Technical University of Mu...

9 May 2018 Europe mechanism | pore-forming

Continue Reading →

Europe

Scotland Leads the Way in Approval of First Licensed Treatment for Life-Threatening Genetic Disease Affecting Children

Routine access to Spinraza® (nusinersen) for type 1 spinal muscular atrophy granted, with discussions continuing to secure access for other forms of the disease The S...

9 May 2018 Europe atrophy | liscenced

Continue Reading →

Europe

Invivoscribe Submits Pre-Market Approval Application in Japan and Panel Track Supplement in the US to Screen Acute Myeloid Leukemia (AML) Patients for FLT3 Mutations

Invivoscribe Technologies, Inc. announced today that they have submitted to Japan's Pharmaceutical and Medical Devices Agency (PMDA) and the US Food and Drug Administ...

9 May 2018 Europe | North America application | approval

Continue Reading →

Europe

Capricor Announces Initiation Of HOPE-2 Clinical Trial Of CAP-1002 For Duchenne Muscular Dystrophy

Capricor Therapeutics, Inc. (NASDAQ:CAPR) today announced it has initiated the HOPE-2 clinical trial at UC Davis Medical Center. The trial will test the safety and ef...

2 May 2018 Europe | North America CAP-1002 | capricor

Continue Reading →

Europe

Novel magnetic nanoparticles move from lab to first breast cancer clinical trials

Sandia National Laboratories materials chemist Dale Huber has been working on the challenge of making iron-based nanoparticles the exact same size for 15 years. Now, ...

2 May 2018 Europe breast | cancer

Continue Reading →

Europe

Virtual drug trials boost results

Belinda H. Tan '96 says virtual drug trials can result in more diverse testing populations and boost non-white particip...

2 May 2018 Europe boosts | drug

Continue Reading →

Europe

Too few women take part in many CVD clinical trials

Women make up a lower than expected proportion of participants in many clinical trials for cardiovascular disease, US researchers have found. The authors of the stud...

2 May 2018 Europe cardiovascular | clinical

Continue Reading →